tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Derek Archila, 260 are a BUY (68.42%), 109 are a HOLD (28.68%), 11 are a SELL (2.89%).
Analyst Derek Archila, currently employed at WELLS FARGO, carries an average stock price target met ratio of 51.63% that have a potential upside of 49.77% achieved within 195 days.
Derek Archila’s has documented 719 price targets and ratings displayed on 65 stocks. The coverage is on Healthcare, Energy, Technology, Financial Services sectors.
Most recent stock forecast was given on CLDX, Celldex Therapeutics at 22-Jul-2026.
Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for EQ (EQUILLIUM) at 7/10/2020. The price target of $10 was fulfilled within 3 days with a profit of $6.81 (213.48%) receiving and performance score of 711.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Dec-2019
$18
5 years 10 months 27 days ago
(01-Sep-2020)
3/3 (100%)
$3.19 (21.54%)
78
Buy Since 17-Nov-2015
$35
$0.51 (1.48%)
5 years 10 months 27 days ago
(31-Aug-2020)
5/14 (35.71%)
$0.78 (2.28%)
488
Hold Since 04-Feb-2020
$34.5
$0.01 (0.03%)
5 years 10 months 27 days ago
(31-Aug-2020)
5/5 (100%)
$0.28 (0.82%)
138
Buy Since 14-Jun-2016
$34.5
$0.01 (0.03%)
$66
5 years 10 months 27 days ago
(31-Aug-2020)
1/9 (11.11%)
$0.28 (0.82%)
39
Buy Since 03-Jun-2019
$60
5 years 10 months 27 days ago
(31-Aug-2020)
0/19 (0%)
$41.31 (221.03%)
Which stock is Derek Archila is most bullish on?
Which stock is Derek Archila is most reserved on?
What Year was the first public recommendation made by Derek Archila?
